Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal
Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer
Tyrosine Kinase Inhibitor Encoraging For NSCLC
Novel Agents Promise Relief From Hematologic Side Effects
Interferon Alpha-2B Effective For Malignant Melanoma
International Group Plans Survey On Thrombosis Risk
NCI-Approved Clinical Trials Listed For June 2001
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- Survivorship begins at diagnosis—cancer care system must recognize this
- Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy









